News

Emboli Filters May Not Work, MRI Shows


 

SCOTTSDALE, ARIZ. — Cerebral protection devices used during carotid stenting procedures do not catch small emboli, and may not prevent stroke and brain damage, according to preliminary results from a study that used diffusion-weighted MRI.

“Cerebral protection devices may not reduce the incidence of new ischemic defects on diffusion-weighted MR,” Dr. Michel S. Makaroun said at an international congress on endovascular interventions sponsored by the Arizona Heart Foundation. “Further investigation is definitely warranted.”

He presented the results of the first 36 patients treated in a planned larger trial comparing distal-filter protection with no protection; the trial is using MRI of the patients' brains before and after a carotid stenting procedure to visualize lesions that might not be readily clinically apparent.

There was no difference, said Dr. Makaroun, director of the endovascular surgery program at the University of Pittsburgh Medical Center. Of 18 patients who were treated with cerebral protection, 13 had at least one white lesion seen on diffusion-weighted imaging after the procedure that had not been there before. In comparison, 8 of 18 patients treated without protection had any white lesion afterward.

The difference was not statistically significant, given the small number of patients, noted Dr. Makaroun.

The average number of new lesions was the same for both groups, six, and the average size of the lesions was the same as well. Two perioperative strokes occurred, one in each treatment group.

Recommended Reading

Strong Role Remains for Primary Lytics Early in MI
MDedge Cardiology
L-Arginine After MI Linked to Higher Mortality
MDedge Cardiology
Telemetry Spots Silent Arrythmia in Stroke Patients
MDedge Cardiology
From Early On, Diabetics Face Higher Stroke Risk
MDedge Cardiology
Cognition Improved by Carotid Artery Stenting : Faster cognition after stenting is related to improved blood perfusion to the brain, imaging study suggests.
MDedge Cardiology
New DES Platforms May Cut Thrombosis Risk
MDedge Cardiology
Nitinol Stents Safe, Effective in Femoral Arteries
MDedge Cardiology
Limited Abciximab in PCI May Facilitate Same-Day Release
MDedge Cardiology
Type A Aortic Dissection Calls for Experience
MDedge Cardiology
20-Year Study Confirms Benefits of MIMA Bypass : The long-term rates of adverse events are decreased, provided the grafts are placed on the two largest vessels.
MDedge Cardiology